您的购物车当前为空
Multitarget AD-IN-4(compound IIIj)是一种多靶点导向配体(MTDL),能够抑制多种胆碱酯酶(EeAChEIC50= 0.157 μM,eqBuChEIC50= 0.147 μM,hAChEIC50= 1.551 μM,hBuChEIC50= 2.152 μM),并具有抗氧化活性和神经保护作用,还可以抑制钙通道(Ca2+通道阻滞的IC50为 30.59 μM)。此外,Multitarget AD-IN-4 能逆转小鼠模型中东莨菪碱诱导的遗忘症,并可应用于阿尔茨海默病(AD)的研究。
Multitarget AD-IN-4(compound IIIj)是一种多靶点导向配体(MTDL),能够抑制多种胆碱酯酶(EeAChEIC50= 0.157 μM,eqBuChEIC50= 0.147 μM,hAChEIC50= 1.551 μM,hBuChEIC50= 2.152 μM),并具有抗氧化活性和神经保护作用,还可以抑制钙通道(Ca2+通道阻滞的IC50为 30.59 μM)。此外,Multitarget AD-IN-4 能逆转小鼠模型中东莨菪碱诱导的遗忘症,并可应用于阿尔茨海默病(AD)的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Multitarget AD-IN-4 (compound IIIj) is a multitarget-directed ligand (MTDL) that concurrently inhibits various cholinesterases, including EeAChE with an IC50 of 0.157 μM, eqBuChE with an IC50 of 0.147 μM, hAChE with an IC50 of 1.551 μM, and hBuChE with an IC50 of 2.152 μM. It also exhibits antioxidant activity, offers neuroprotection, and inhibits calcium channels with an IC50 of 30.59 μM. Furthermore, Multitarget AD-IN-4 can reverse scopolamine-induced amnesia in mouse models and is applicable for Alzheimer's disease (AD) research. |
| 靶点活性 | Ca2+ channel:30.59 μM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多